Production of lactulose API (Active Pharmaceutical Ingredients) is in line with current guidelines of Good Manufacturing Practice (GMP/cGMP) and complies with all relevant specifications (including European Pharmacopoeia (Ph.Eur./EP), U.S. Pharmacopoeia (USP), and Japanese Pharmacopoeia (JP)).
Our customers and various authorities from all over the world regularly inspect and approve the strict adherence to EU GMP and US cGMP regulations for all our processes, from raw material to the finished product.
Manufacture
Fresenius Kabi Austria GmbH is one of the world‘s major lactulose suppliers, with more than 50 years of experience in its production and distribution. We manufacture and distribute lactulose in liquid and crystalline form, as a food or animal-feed ingredient, an Active Pharmaceutical Ingredient (API) or finished, packaged medicinal products.
For more information on our lactulose product portfolio and services, please also visit our websites www.fresenius-kabi.at.
